Ep135: John Maraganore on Developing a New Class of Medicines
The Long Run with Luke Timmerman
00:00
Partnerships for validation and funding
John reviews strategic deals with Merck, Novartis and Roche that provided validation, funding, and runway for Alnylam.
Play episode from 25:59
Transcript
